An unusual case of bloom syndrome presenting with basal cell carcinoma

Dermatologic Surgery

Volumn 35, Issue 1, 2009, Pages 131-134

  Draznin, Michelle ^a   Robles, David T ^a   Nguyen, Viet ^a   Berg, Daniel ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; HELICASE; RECQ HELICASE; TOPOISOMERASE IIIALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASAL CELL CARCINOMA; BLOOM SYNDROME; CANCER GROWTH; CASE REPORT; CHEMOSURGERY; DISEASE PREDISPOSITION; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MALE; METASTASIS; PATIENT REFERRAL; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CANCER; T CELL LYMPHOMA;

ADULT; BLOOM SYNDROME; CARCINOMA, BASAL CELL; HUMANS; MALE; SKIN NEOPLASMS;

EID: 58149291611     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2008.34393.x     Document Type: Article

References (28)

1. German J. Bloom's syndrome. Dermatol Clin 1995 13 : 7 18.
2. Diaz A, Vogiatzi MG, Sanz MM, German J. Evaluation of short stature, carbohydrate metabolism and other endocrinopathies in Bloom's syndrome. Horm Res 2006 66 : 111 7.
3. Risinger MA, Groden J. Crosslinks and crosstalk: human cancer syndromes and DNA repair defects. Cancer Cell 2004 6 : 539 45.
4. Cheok CF, Bachrati CZ, Chan KL, et al. Roles of the Bloom's syndrome helicase in the maintenance of genome stability. Biochem Soc Trans 2005 33 (Pt 6) : 1456 9.
5. Mohaghegh P, Hickson ID. The Bloom's syndrome helicase: keeping cancer at bay. Biologist (London) 2003 50 : 29 33.
6. Karmakar P, Seki M, Kanamori M, et al. BLM is an early responder to DNA double-strand breaks. Biochem Biophys Res Commun 2006 348 : 62 9.
7. Chester N, Babbe H, Pinkas J, et al. Mutation of the murine Bloom's syndrome gene produces global genome destabilization. Mol Cell Biol 2006 26 : 6713 26.
8. McDaniel LD, Chester N, Watson M, et al. Chromosome instability and tumor predisposition inversely correlate with BLM protein levels. DNA Repair (Amsterdam) 2003 2 : 1387 404.
9. German J Bloom's syndrome. XX. The first 100 cancers. Cancer Genet Cytogenet 1997 93 : 100 6.
10. Bachrati CZ, Hickson ID. RecQ helicases: suppressors of tumorigenesis and premature aging. Biochem J 2003 374 (Pt 3) : 577 606.
11. Wirtenberger M, Frank B, Hemminki K, et al. Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer. Carcinogenesis 2006 27 : 1655 60.
12. Li L, Eng C, Desnick RJ, et al. Carrier frequency of the Bloom syndrome blmAsh mutation in the Ashkenazi Jewish population. Mol Genet Metab 1998 64 : 286 90.
13. Braathen LR, Szeimies RM. International Society for Photodynamic Therapy in Dermatology et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol 2007 56 : 125 43.
14. Ferreres JR, Macaya A, Jucglà A, et al. Hundreds of basal cell carcinomas in a Gorlin-Goltz syndrome patient cured with imiquimod 5% cream. J Eur Acad Dermatol Venereol 2006 20 : 877 8.
15. Vereecken P, Monsieur E, Petein M, Heenen M. Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome. J Dermatol Treat 2004 15 : 120 1.
16. Micali G, Lacarrubba F, Nasca MR, De Pasquale R The use of imiquimod 5% cream for the treatment of basal cell carcinoma as observed in Gorlin's syndrome. Clin Exp Dermatol 2003 28 (Suppl 1) : 19 23.
17. Micali G, De Pasquale R, Caltabiano R, et al. Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report. J Dermatol Treat 2002 13 : 123 7.
18. Kagy MK, Amonette R. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatol Surg 2000 26 : 577 8 discussion 578 9.
19. van Ruth S, Jansman FG, Sanders CJ. Total body topical 5-fluorouracil for extensive non-melanoma skin cancer. Pharm World Sci 2006 28 : 159 62 Epub 2006 Sep 27.
20. Tsuji T, Otake N, Nishimura M. Cryosurgery and topical fluorouracil: a treatment method for widespread basal cell epithelioma in basal cell nevus syndrome. J Dermatol 1993 20 : 507 13.
21. Strange PR, Lang PG Jr. Long-term management of basal cell nevus syndrome with topical tretinoin and 5-fluorouracil. J Am Acad Dermatol 1992 27 (5 Pt 2) : 842 5.
22. Hazen PG, Taub SJ. Basal cell nevus syndrome. Unresponsiveness of early cutaneous lesions to topical 5-fluorouracil or dinitrochlorobenzene. Dermatologica 1984 168 : 287 9.
23. Amon RB, Goodkin PE. Topical 5-fluorouracil and the basal-cell-nevus syndrome. N Engl J Med 1976 295 : 677 8.
24. Sollitto RB, DiGiovanna JJ. Failure of interferon alfa and isotretinoin combination therapy in the nevoid basal cell carcinoma syndrome. Arch Dermatol 1996 132 : 94 5.
25. Sanchez-Conejo-Mir J, Camacho F. Nevoid basal cell carcinoma syndrome: combined etretinate and surgical treatment. J Dermatol Surg Oncol 1989 15 : 868 71.
26. Goldberg LH, Hsu SH, Alcalay J. Effectiveness of isotretinoin in preventing the appearance of basal cell carcinomas in basal cell nevus syndrome. J Am Acad Dermatol 1989 21 : 144 5.
27. Hodak E, Ginzburg A, David M, Sandbank M. Etretinate treatment of the nevoid basal cell carcinoma syndrome. Therapeutic and chemopreventive effect. Int J Dermatol 1987 26 : 606 9.
28. Cristofolini M, Zumiani G, Scappini P, Piscioli F. Aromatic retinoid in the chemoprevention of the progression of nevoid basal-cell carcinoma syndrome. J Dermatol Surg Oncol 1984 10 : 778 81.